General Practice Doctors in Ellsworth Afb, SD Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Kevin Anderson, MD General Practice Medicare: Medicare Enrolled Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-3332

Maxwell Tuo Cheng, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-6700

Dr. Olivia Michelle Vaughan, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-3111

News Archive

Many people mistaken about the causes of cancer

A large international survey for the International Union Against Cancer (UICC) has revealed that many people have misconceptions about what causes cancer.

Winner of 'The Voice' to perform at MMRF Fall Gala on October 29

The Multiple Myeloma Research Foundation (MMRF) announced today that Javier Colon, winner of NBC's The Voice, will join the lineup of featured artists performing a tribute concert celebrating music industry icon Stevie Wonder at the MMRF Fall Gala, to be held October 29, 2011, at the Hyatt Regency Greenwich in Old Greenwich, Connecticut.

Dining out may boost levels of health-harming phthalates in the body

Dining out more at restaurants, cafeterias and fast-food outlets may boost total levels of potentially health-harming chemicals called phthalates in the body, according to a study out today. Phthalates, a group of chemicals used in food packaging and processing materials, are known to disrupt hormones in humans and are linked to a long list of health problems.

Special issue of AIDS and Behavior looks at latest behavioral interventions research

HIV prevention must be better targeted, according to David Holtgrave from Johns Hopkins Bloomberg School of Public Health in the US, and colleagues. Health care professionals need a more detailed analysis and understanding of the interplay between HIV risk behavior, access to treatment and treatment success among those living with HIV. The authors discuss their proposed framework in a study in a special issue of Springer's journal AIDS and Behavior.

ISP of Chile approves Trigemina's protocol for Phase 2 clinical study of TI-001

Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that the Instituto de Salud Publica of Chile has approved the Company's protocol for its Phase 2 clinical study of TI-001, intranasal oxytocin, for the treatment of chronic migraine.

Read more Medical News

› Verified 8 days ago